164 related articles for article (PubMed ID: 26846985)
1. Natural history of age-related lobular involution and impact on breast cancer risk.
Radisky DC; Visscher DW; Frank RD; Vierkant RA; Winham S; Stallings-Mann M; Hoskin TL; Nassar A; Vachon CM; Denison LA; Hartmann LC; Frost MH; Degnim AC
Breast Cancer Res Treat; 2016 Feb; 155(3):423-30. PubMed ID: 26846985
[TBL] [Abstract][Full Text] [Related]
2. Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution.
Stallings-Mann ML; Heinzen EP; Vierkant RA; Winham SJ; Hoskin TL; Denison LA; Nassar A; Hartmann LC; Visscher DW; Frost MH; Sherman ME; Degnim AC; Radisky DC
Breast Cancer Res Treat; 2017 Nov; 166(1):133-143. PubMed ID: 28752190
[TBL] [Abstract][Full Text] [Related]
3. Independent association of lobular involution and mammographic breast density with breast cancer risk.
Ghosh K; Vachon CM; Pankratz VS; Vierkant RA; Anderson SS; Brandt KR; Visscher DW; Reynolds C; Frost MH; Hartmann LC
J Natl Cancer Inst; 2010 Nov; 102(22):1716-23. PubMed ID: 21037116
[TBL] [Abstract][Full Text] [Related]
4. Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study.
Figueroa JD; Pfeiffer RM; Brinton LA; Palakal MM; Degnim AC; Radisky D; Hartmann LC; Frost MH; Stallings Mann ML; Papathomas D; Gierach GL; Hewitt SM; Duggan MA; Visscher D; Sherman ME
Breast Cancer Res Treat; 2016 Aug; 159(1):163-72. PubMed ID: 27488681
[TBL] [Abstract][Full Text] [Related]
5. Association between mammographic density and age-related lobular involution of the breast.
Ghosh K; Hartmann LC; Reynolds C; Visscher DW; Brandt KR; Vierkant RA; Scott CG; Radisky DC; Sellers TA; Pankratz VS; Vachon CM
J Clin Oncol; 2010 May; 28(13):2207-12. PubMed ID: 20351335
[TBL] [Abstract][Full Text] [Related]
6. Age-related lobular involution and risk of breast cancer.
Milanese TR; Hartmann LC; Sellers TA; Frost MH; Vierkant RA; Maloney SD; Pankratz VS; Degnim AC; Vachon CM; Reynolds CA; Thompson RA; Melton LJ; Goode EL; Visscher DW
J Natl Cancer Inst; 2006 Nov; 98(22):1600-7. PubMed ID: 17105983
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 2 breast cancer risk models in a benign breast disease cohort.
Frank RD; Winham SJ; Vierkant RA; Frost MH; Radisky DC; Ghosh K; Brandt KR; Sherman ME; Visscher DW; Hartmann LC; Degnim AC; Vachon CM
Cancer; 2018 Aug; 124(16):3319-3328. PubMed ID: 29932456
[TBL] [Abstract][Full Text] [Related]
8. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.
Tice JA; Miglioretti DL; Li CS; Vachon CM; Gard CC; Kerlikowske K
J Clin Oncol; 2015 Oct; 33(28):3137-43. PubMed ID: 26282663
[TBL] [Abstract][Full Text] [Related]
9. Using Digital Pathology to Understand Epithelial Characteristics of Benign Breast Disease among Women Undergoing Diagnostic Image-Guided Breast Biopsy.
Mullooly M; Puvanesarajah S; Fan S; Pfeiffer RM; Olsson LT; Hada M; Kirk EL; Vacek PM; Weaver DL; Shepherd J; Mahmoudzadeh A; Wang J; Malkov S; Johnson JM; Hewitt SM; Herschorn SD; Sherman ME; Troester MA; Gierach GL
Cancer Prev Res (Phila); 2019 Dec; 12(12):861-870. PubMed ID: 31645342
[TBL] [Abstract][Full Text] [Related]
10. Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease.
Arthur R; Wang Y; Ye K; Glass AG; Ginsberg M; Loudig O; Rohan T
Breast Cancer Res Treat; 2017 Oct; 165(3):623-631. PubMed ID: 28643020
[TBL] [Abstract][Full Text] [Related]
11. Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.
Horne HN; Sherman ME; Pfeiffer RM; Figueroa JD; Khodr ZG; Falk RT; Pollak M; Patel DA; Palakal MM; Linville L; Papathomas D; Geller B; Vacek PM; Weaver DL; Chicoine R; Shepherd J; Mahmoudzadeh AP; Wang J; Fan B; Malkov S; Herschorn S; Hewitt SM; Brinton LA; Gierach GL
Breast Cancer Res; 2016 Feb; 18(1):24. PubMed ID: 26893016
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.
Visscher DW; Frank RD; Carter JM; Vierkant RA; Winham SJ; Heinzen EP; Broderick BT; Denison LA; Allers TM; Johnson JL; Frost MH; Hartmann LC; Degnim AC; Radisky DC
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28376198
[TBL] [Abstract][Full Text] [Related]
13. Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort.
Vierkant RA; Degnim AC; Radisky DC; Visscher DW; Heinzen EP; Frank RD; Winham SJ; Frost MH; Scott CG; Jensen MR; Ghosh K; Manduca A; Brandt KR; Whaley DH; Hartmann LC; Vachon CM
BMC Cancer; 2017 Jan; 17(1):84. PubMed ID: 28143431
[TBL] [Abstract][Full Text] [Related]
14. Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities.
Gierach GL; Patel DA; Pfeiffer RM; Figueroa JD; Linville L; Papathomas D; Johnson JM; Chicoine RE; Herschorn SD; Shepherd JA; Wang J; Malkov S; Vacek PM; Weaver DL; Fan B; Mahmoudzadeh AP; Palakal M; Xiang J; Oh H; Horne HN; Sprague BL; Hewitt SM; Brinton LA; Sherman ME
Cancer Prev Res (Phila); 2016 Feb; 9(2):149-58. PubMed ID: 26645278
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population.
Worsham MJ; Abrams J; Raju U; Kapke A; Lu M; Cheng J; Mott D; Wolman SR
Breast J; 2007; 13(2):115-21. PubMed ID: 17319851
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy.
Sherman ME; Vierkant RA; Kaggal S; Hoskin TL; Frost MH; Denison L; Visscher DW; Carter JM; Winham SJ; Jensen MR; Radisky DC; Vachon CM; Degnim AC
Cancer Prev Res (Phila); 2020 Nov; 13(11):967-976. PubMed ID: 32718942
[TBL] [Abstract][Full Text] [Related]
17. Alcohol consumption and incidence of benign breast disease.
Byrne C; Webb PM; Jacobs TW; Peiro G; Schnitt SJ; Connolly JL; Willett WC; Colditz GA
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1369-74. PubMed ID: 12433713
[TBL] [Abstract][Full Text] [Related]
18. Age-related terminal duct lobular unit involution in benign tissues from Chinese breast cancer patients with luminal and triple-negative tumors.
Guo C; Sung H; Zheng S; Guida J; Li E; Li J; Hu N; Deng J; Figueroa JD; Sherman ME; Gierach GL; Lu N; Yang XR
Breast Cancer Res; 2017 May; 19(1):61. PubMed ID: 28545469
[TBL] [Abstract][Full Text] [Related]
19. Lower-category benign breast disease and the risk of invasive breast cancer.
Wang J; Costantino JP; Tan-Chiu E; Wickerham DL; Paik S; Wolmark N
J Natl Cancer Inst; 2004 Apr; 96(8):616-20. PubMed ID: 15100339
[TBL] [Abstract][Full Text] [Related]
20. Model for individualized prediction of breast cancer risk after a benign breast biopsy.
Pankratz VS; Degnim AC; Frank RD; Frost MH; Visscher DW; Vierkant RA; Hieken TJ; Ghosh K; Tarabishy Y; Vachon CM; Radisky DC; Hartmann LC
J Clin Oncol; 2015 Mar; 33(8):923-9. PubMed ID: 25624442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
